What do women really want to know? Motives for attending familial breast cancer clinics

Genetic counselling is a highly specialised service in medical care. The service is expensive and its task is comprehensive, including “starting a communication process which deals with the human problems associated with the risk of occurrence of a genetic disorder in a family”.1 For a breast cancer service, this process is an attempt to assist the counsellee in understanding the medical facts, the mode of inheritance, the risk of getting breast and/or ovarian cancer (again), and the implications for daily life. Options for dealing with the risk are discussed and counsellees, depending on their own cumulative risk of getting breast cancer, are presented with a choice of surveillance of their breasts, DNA testing, or prophylactic mastectomy, either with or without oophorectomy. An ever increasing number of women from breast cancer families visit familial cancer clinics for genetic counselling. Because of the comprehensive task of genetic counselling and the increasing numbers of appointments, it is important that the geneticist optimally and efficiently recognises the informational needs that are essential to the counsellee.2 For the counsellee, it is important that she should receive all the information to make a conscious choice. One possible approach is to assess the specific motives for women to attend a familial breast cancer clinic. In this respect, different sets of motives may require different sets of information. Several studies have examined individual motives for attending familial breast cancer clinics and much insight has been gleaned into the most common ones.3–9 Motives often encountered for attending these clinics included: “to find out my risk”, “knowledge of my family history”, “to find out the risk to other family members”, “to reduce my worry”, “to find out about genetic testing”, and “to get information about preventive methods”. Some of these studies3,4,10 simply focused …

[1]  W. Foulkes,et al.  An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling , 2000, Journal of medical genetics.

[2]  P. Devilee,et al.  Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.

[3]  A. Clarke,et al.  Why do women attend familial breast cancer clinics? , 2000, Journal of medical genetics.

[4]  Julie O. Culver,et al.  Genetic counseling for women with an intermediate family history of breast cancer. , 2000, American journal of medical genetics.

[5]  J. Pruski,et al.  Participation in breast cancer risk counseling among women with a family history. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  J. Goodship,et al.  Genetic counselling: do we recognise and meet the consultands’ agenda? , 1999, Journal of medical genetics.

[7]  J. Allanson,et al.  Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer , 1999, Clinical genetics.

[8]  J. Kievit,et al.  The assessment of genetic risk of breast cancer: a set of GP guidelines. , 1999, Family practice.

[9]  Y. Bignon,et al.  Cancer genetic clinics: why do women who already have cancer attend? , 1998, European journal of cancer.

[10]  B. Rimer,et al.  Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Aaronson,et al.  Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members. , 1997, Patient education and counseling.

[12]  Y. Bignon,et al.  Cancer genetics clinics: target population and consultees' expectations. , 1996, European journal of cancer.

[13]  B. Ponder,et al.  Genetic testing in breast/ovarian cancer (BRCA1) families , 1995, The Lancet.

[14]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Stefanek,et al.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. , 1994, Journal of the National Cancer Institute. Monographs.

[16]  G. van Ommen,et al.  Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. , 1993, American journal of medical genetics.

[17]  D. Anderson,et al.  Some characteristics of familial breast cancer , 1971, Cancer.

[18]  D. Danks Genetic counselling. , 1967, Scottish medical journal.